Synthetic biology-inspired cell engineering in diagnosis, treatment, and drug development

N Zhao, Y Song, X Xie, Z Zhu, C Duan… - … and Targeted Therapy, 2023 - nature.com
The fast-developing synthetic biology (SB) has provided many genetic tools to reprogram
and engineer cells for improved performance, novel functions, and diverse applications …

The role of tissue-resident macrophages in the development and treatment of inflammatory bowel disease

S Ma, J Zhang, H Liu, S Li, Q Wang - Frontiers in cell and …, 2022 - frontiersin.org
Inflammatory bowel disease (IBD), comprising Crohn's disease and ulcerative colitis, is a
refractory disease with many immune abnormalities and pathologies in the gastrointestinal …

ROS-responsive hyaluronic acid hydrogel for targeted delivery of probiotics to relieve colitis

L Huang, J Wang, L Kong, X Wang, Q Li… - International Journal of …, 2022 - Elsevier
Probiotics are generally used as therapeutic intervention in inflammatory bowel disease.
However, the low survival rate in harsh gastrointestinal environment and limited retention in …

Tumor-targeted nanomedicine for immunotherapy

H Cabral, H Kinoh, K Kataoka - Accounts of chemical research, 2020 - ACS Publications
Conspectus Therapeutic manipulation of the immune system against cancer has
revolutionized the treatment of several advanced-stage tumors. While many have benefited …

[HTML][HTML] Inflammation-specific targeted carriers for local drug delivery to inflammatory bowel disease

NG Kotla, R Singh, BV Baby, S Rasala, J Rasool… - Biomaterials, 2022 - Elsevier
Delivering drugs directly to the inflamed intestinal sites to treat inflammatory bowel disease
(IBD), particularly Crohn's and ulcerative colitis, is highly challenging. Recent advances in …

Prodrug integrated envelope on probiotics to enhance target therapy for ulcerative colitis

K Zhang, L Zhu, Y Zhong, L Xu, C Lang… - Advanced …, 2023 - Wiley Online Library
Ulcerative colitis (UC), affecting millions of patients worldwide, is associated with disorders
of the gut microbiota. Probiotics‐based therapy positively regulating the community structure …

[HTML][HTML] Receptor-mediated targeted drug delivery systems for treatment of inflammatory bowel disease: Opportunities and emerging strategies

P Liu, C Gao, H Chen, CT Vong, X Wu, X Tang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Inflammatory bowel disease (IBD) is a chronic intestinal disease with painful clinical
manifestations and high risks of cancerization. With no curative therapy for IBD at present …

Nanocrystalline cellulose modulates dysregulated intestinal barriers in ulcerative colitis

M Wang, R Cha, W Hao, X Jiang - ACS nano, 2023 - ACS Publications
Ulcerative colitis (UC) is a recurrent chronic inflammation of the colon with increasing
incidence and prevalence, which could increase the risk of colorectal cancer. It is urgent to …

1,2-Bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic Acid Acetoxymethyl Ester Loaded Reactive Oxygen Species Responsive Hyaluronic Acid–Bilirubin …

Y Wang, M Pu, J Yan, J Zhang, H Wei, L Yu, X Yan… - ACS …, 2022 - ACS Publications
Calcium overload is one of the early determinants of the core cellular events that contribute
to the pathogenesis of acute kidney injury (AKI), which include oxidative stress, ATP …

[HTML][HTML] Orally administered titanium carbide nanosheets as anti-inflammatory therapy for colitis

L Hou, F Gong, B Liu, X Yang, L Chen, G Li, Y Gong… - Theranostics, 2022 - ncbi.nlm.nih.gov
Rationale: Oxidative stress, resulting from excessive reactive oxygen species (ROS), plays
an important role in the initiation and progression of inflammatory bowel disease (IBD) …